Three October 2026 HHS Rules: What Changes for Health Plans, Food Makers and Child Welfare

Three federal documents involving the Health and Human Services Department appear in the Federal Register in early October 2026, and they affect quite different parts of the health and social-service sector ^[1][2][3]. Two are final rules. One is a joint Treasury, Labor and HHS rule revising the Transparency in Coverage price disclosure requirements, and the other is a Food and Drug Administration (FDA) rule permitting salt substitutes in standardized foods ^[1][2]. The third is a proposed rule from the Administration for Children and Families (ACF) to remove regulations that implement title IV-B of the Social Security Act ^[3]. This piece sets out what each document changes, only as far as the official summaries allow ^[1][2][3].

Transparency in Coverage: machine-readable files and consumer access

The Transparency in Coverage final rules are Federal Register document 2026-20447, published October 6, 2026 ^[2]. They amend regulations under three statutes: the Public Health Service Act, the Employee Retirement Income Security Act of 1974 and the Internal Revenue Code ^[2]. They govern price transparency reporting by two groups: non-grandfathered group health plans, and health insurance issuers offering non-grandfathered group and individual coverage ^[2]. The stated aim is to improve the standardization, accuracy and accessibility of public pricing disclosures, in line with Executive Order 14221, "Making America Healthy Again by Empowering Patients With Clear, Accurate, and Actionable Healthcare Pricing Information" ^[2].

Many of the changes concern machine-readable files, the public pricing data files that plans and issuers must disclose under these rules ^[2]. The summary names two of these files, the In-network Rate file and the out-of-network Allowed Amount file, and lists the following changes for them ^[2]:

• New contextual files are added ^[2].
• Additional data elements are required, including product type, provider network name and provider network identifier ^[2].
• The reporting level at which data are aggregated is changed ^[2].
• In-network rates are removed for what the summary calls unlikely provider-to-service mappings ^[2].
• For out-of-network historical data, the reporting period is increased and the claims threshold is lowered ^[2].
• The reporting cadence is reduced ^[2].

A second group of changes is meant to make the files easier to find ^[2]. These apply to all machine-readable files required under the Transparency in Coverage rules, including the prescription drug file ^[2]. Plans and issuers must post a text file containing contact information for the files and add a footer with website URLs ^[2].

The rules also change how consumers can get pricing information ^[2]. Pricing information made available through an online consumer tool and on paper upon request must also be made available by phone ^[2]. Meeting this phone requirement also satisfies section 114 of the No Surprises Act ^[2]. That equivalence extends to grandfathered group health plans and to issuers offering grandfathered group and individual coverage, which are otherwise outside these final rules ^[2].

Organizations that sponsor a non-grandfathered group health plan, and issuers offering non-grandfathered group or individual coverage, fall within the scope the summary describes ^[2].

FDA: salt substitutes in standardized foods

The FDA final rule is Federal Register document 2026-20848, with a Federal Register publication date of October 13, 2026 ^[1]. It amends standard of identity regulations, which define what a standardized food must or may contain ^[1]. Specifically, it covers the regulations that list salt (sodium chloride) as a required or optional ingredient, and it permits salt substitutes in those foods to reduce their sodium content ^[1].

The agency's rationale is that reducing sodium may help reduce the risk of hypertension, which it describes as a major risk factor for heart disease and stroke ^[1]. This is a statement of regulatory purpose; the summary reports no study, population or effect size behind it ^[1]. The FDA also says the rule gives industry flexibility to develop lower-sodium standardized foods while keeping the basic nature and essential characteristics of those foods ^[1].

The direct effect is a change in what standardized foods may contain, and the summary does not say which foods or which substitutes are covered ^[1].

ACF: proposed removal of title IV-B regulations

The ACF document is a proposed rule, Federal Register document 2026-20329, published October 5, 2026 ^[3]. ACF proposes to remove regulations that implement title IV-B of the Social Security Act ^[3]. It gives four reasons, which may apply singly or together ^[3]:

• Some regulations are outdated and refer to dates that have passed ^[3].
• Some have been superseded by later amendments to the Act ^[3].
• Some duplicate or restate requirements already in title IV-B or other federal law ^[3].
• Some impose administrative and reporting requirements on agencies that ACF says do not meaningfully support federal oversight and administration of title IV-B programs ^[3].

Not every requirement would disappear. Four of the regulatory requirements would be redesignated, meaning moved, to the regulations addressing title IV-E and IV-B plan requirements ^[3]. ACF also proposes to remove the regulation setting out the principles of child and family services reviews ^[3]. Its reasoning is that this regulation prescribes no requirements that states and tribes must follow and offers only unenforceable recommendations ^[3]. Redundant cross-references would also be removed ^[3].

The summary describes the administrative and reporting requirements at issue as falling on agencies, and the review principles as addressed to states and tribes ^[3]. Because this is a proposed rule, the changes are not yet final, whereas the two documents above are final rules ^[1][2][3].

Limitations

This explainer relies only on the official Federal Register summaries, which leave out much of the operational detail ^[1][2][3]. Key gaps are:

• The Transparency in Coverage summary gives no effective or applicability dates ^[2].
• It does not give the new claims threshold, the length of the new reporting period or the new reporting cadence ^[2].
• It does not define the new aggregation level or the criteria for an unlikely provider-to-service mapping ^[2].
• The FDA summary does not list the affected foods, the eligible salt substitutes or the effective date ^[1].
• The ACF summary does not identify the four redesignated requirements or give a comment deadline ^[3].

The full rule text in each document is where these details would be found ^[1][2][3].